New diagnostic and therapeutic tools
against multidrug resistant tumours

Pharmacokinetics and ADMET of the new therapeutic tools; safety of the targets

In WG4 we run the pharmacokinetic and ADME-toxicology evaluation of synthetic and natural compounds  and their formulations, which were developed by WG2, correlated with the therapeutic targets identified by WG1 and tested for their efficacy by WG3. We will use a broad series of in silico, in vitro and in vivo assays. The overall aim is the safety assessment of the hitting therapeutic targets identified by WG1.

Information about WG4 meetings

WG4 Members

Total 30 participants
Alfonso GARCIA SOSAGoogle Scholar
Ana VUJAČIĆ NIKEZIĆ
Andreas SCORILAS
Andrei LUCA
Aylin KOSËLER
Denitsa ALUANI
Evren GUNDOGDU
Fabio FUSI
Hannu RAUNIO
Ignacio OCHOA GARRIDO
Ilza PAJEVA
Ivanka TSAKOVSKA
Jelena DINIC
José M. PADRÓNGoogle Scholar
Lana NEZIC
Marialessandra CONTINO
Mauro ALINI
Miriam DURANTE
Mirjana STANIC
Olli PENTIKÄINEN
Petko ALOV
Risto JUVONEN
Sanna NIINIVEHMAS
Simona SAPONARA
Simonida CRVENKOVA
Tatar GIZEM
Tiziano SERRA
Vesna JAĆEVIĆ
Virginia TZANKOVA
Yordan YORDANOV